P34: safety and immunological response to 300ir house dust mite sublingual tablets in four phase iii trials

Internal Medicine Journal,Volume 48, Issue S6, Page 14-14, November 2018.
Source: Internal Medicine Journal - Category: Internal Medicine Source Type: research